Cheryl Reeves, Senior Editor at The Lancet Oncology, is joined by Professor James Nagarajah to discuss his open-label, randomised, phase 2 study [177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE). Click here to read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00762-4/fulltext Tel ... Show More
May 31
Hedvig Hricak and Zachary Ward on Cancer workforce—a global crisis: a Lancet Oncology Commission
Jamie Prowse, Senior Editor at The Lancet Oncology, is joined by Dr Hedvig Hricak (Memorial Sloan Kettering Cancer Center, New York, NY, USA) and Dr Zachary Ward (Harvard TH Chan School of Public Health, Boston, MA, USA) to discuss Cancer workforce—a global crisis: a Lancet Oncol ... Show More
23m 36s
Apr 27
Fred Saad on quality of life in patients with metastatic hormone-sensitive prostate cancer
Cheryl Lai, Acting Deputy Editor of The Lancet Oncology, is joined by Professor Fred Saad (Department of Surgery/Urology, University of Montreal, Montreal, QC, Canada) to discuss pain and health-related quality-of-life outcomes from the randomised phase 3 ARANOTE trial of darolut ... Show More
13m 1s
Jun 2024
Cancer Prevention with Dr. Leigh Erin Connealy, MD
<p>Today I am speaking with <strong>Dr. Leigh Erin Connealy, MD. Dr. Connealy is </strong>absolutely<strong> </strong>amazing, and I was so interested to have her on the podcast because of her incredible experience and philosophy on cancer prevention. </p>
<p>We discuss cancer ra ... Show More
1h 3m
Mar 2025
Dr. Patrick Soon-Shiong: You’re Being Lied to About Cancer, How It’s Caused, and How to Stop It
Dr. Patrick Soon-Shiong is a surgeon who made billions inventing cancer drugs. He says that Covid, and the vaccines that didn’t stop it, are likely causing a global epidemic of terrifyingly aggressive cancers.
(00:00) Why Are Cancer Rates Rising in Young People?
(06:16) What Is ... Show More
1h 52m